Clinical and Biochemical Effect of Aminoglutethimide in the Treatment of Advanced Prostatic Carcinoma
Authors:
- 1 January 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 129 (1) , 51-55
Abstract
Treatment of male patients with advanced prostatic carcinoma and disease progression after initial endocrine therapy frequently is unsatisfactory. However, approximately 20 per cent of these patients respond to surgical adrenalectomy or hypophysectomy, indicating continued hormonal responsiveness. A total of 25 previously castrated men with stage D carcinoma received 1,000 mg. aminoglutethimide and 40 mg. hydrocortisone daily. The patients were evaluated using the criteria of the National Prostatic Cancer Project. One patient has had a complete response and is in remission after 275 weeks of therapy. A partial response was noted in 4 patients, while the disease was objectively stable in 6. Pre-treatment testosterone and dihydrotestosterone levels were measured in 9 of 25 patients and were significantly reduced statistically during aminoglutethimide therapy (p less than 0.01). Response and drug toxicity are discussed.Keywords
This publication has 23 references indexed in Scilit:
- How Effective Is Surgical Adrenalectomy in Lowering Steroid Hormone Concentrations?*The Journal of Clinical Endocrinology & Metabolism, 1982
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.Journal of Clinical Investigation, 1980
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.Journal of Clinical Investigation, 1979
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*The Journal of Clinical Endocrinology & Metabolism, 1978
- Current Status of Bilateral Adrenalectomy or Advanced Prostatic CarcinomaAnnals of Surgery, 1974
- Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic CancerBritish Journal of Urology, 1973
- Aminoglutethimide: a ‘side-effect’ turned to therapeutic advantagePostgraduate Medical Journal, 1970
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970